Metagenomi’s planned jump to Wall Street could be a bellwether for other startups looking to go public in 2024.Dive Brief:Metagenomi, a biotechnology startup working to identify new CRISPR enzymes for editing genes, has filed to go public.Backed by healthcare investors and pharmaceutical firms including Novo Nordisk’s parent company and Bayer’s venture arm, Metagenomi most recently […]